eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors

February 16, 2026 updated by: Royal College of Surgeons, Ireland
This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Head and neck cancer (HNC) survivors experience significant long-term physical, functional, and psychosocial sequelae including dysphagia, speech impairment, fatigue, pain, and psychological distress. Traditional follow-up models rely on periodic clinic visits and may not adequately support self-management.

This study involves three phases:

Development of a co-designed eHealth support platform.

Implementation of the intervention within survivorship care pathways.

Evaluation of clinical effectiveness using patient-reported outcomes and healthcare utilization metrics.

The intervention integrates:

Symptom tracking Educational resources Self-management tools Structured nurse-guided follow-up

The primary hypothesis is that structured digital survivorship support will improve global quality of life compared to usual follow-up care.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ireland
      • Beaumont, Ireland, D09V2N0
        • Beaumont RCSI Cancer Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent

Exclusion Criteria:

Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention

Intervention Name: eHealth Survivorship Support Tool

Description:

A digital platform including:

Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up
Other: eHealth Survivorship Support Tool

A digital platform including:

Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up
Active Comparator: Control
Participants receive standard survivorship follow-up as per institutional guidelines.
Other: Control
Standard follow up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life EORTC QLQ-C30 (Global Health Status scale)
Time Frame: Baseline, 3 months, 6 months
Measurement Tool: EORTC QLQ-C30 (Global Health Status scale) Time Frame: Baseline, 3 months, 6 months
Baseline, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Royal College of Surgeons, Ireland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Estimated)

October 12, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

February 16, 2026

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 23, 2026

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BH-REC-eHealth-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe